Product Description
| Brand | Abbott |
| Sample Type | Nasal/ Oropharyngeal/ Nasopharynx |
| Test Type | Covid, Influenza A&B 2, RSV, Strep A2 |
| CAT No | NAT-000 |
ID NOW is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique ID NOW isothermal nucleic acid amplification technology provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.
Rapid, Point-of-Care Molecular TestingExperience high-accuracy, rapid molecular identification of pathogens with the Abbott ID NOW. Its innovative INAAT technology delivers results in as little as 5 minutes, enabling healthcare professionals to make timely decisions. Suited for a wide array of infectious diseases, this device streamlines diagnostics in busy clinical settings or on the go.
User-Friendly and Portable DesignThe Abbott ID NOW instrument is engineered for convenience. Weighing only 2.9 kg and featuring a compact footprint, it is easily transportable between locations. With an intuitive LCD touch screen and clear LED indicator, the operation is straightforward, requiring only basic training for healthcare professionals. The device is built from durable ABS plastic and designed for longevity.
Flexible and Connected OperationSupporting USB and optional network connectivity, the ID NOW integrates seamlessly into various clinical IT environments. Its low maintenance design allows for easy cleaning and hassle-free start-up within five minutes. Single sample throughput ensures focused, individualized testing ideal for urgent patient care environments.
FAQ's of Abbott ID NOW:
Q: How does the Abbott ID NOW deliver rapid diagnostic results?
A: The Abbott ID NOW uses advanced isothermal nucleic acid amplification (INAAT) to rapidly amplify and detect target pathogens in biological samples. This technology allows the device to provide qualitative test results in as little as 5 to 13 minutes, much faster than traditional molecular diagnostic instruments.
Q: What types of samples can the Abbott ID NOW analyze, and what diseases can it detect?
A: This instrument is designed for nasopharyngeal, nasal, or throat swab samples. It is commonly used to detect infectious diseases such as COVID-19, Influenza A & B, RSV, and Strep A, supporting timely clinical decision-making.
Q: When is the Abbott ID NOW most beneficial to use in clinical workflows?
A: The device is especially valuable when rapid and accurate diagnosis is critical, such as in emergency rooms, outpatient clinics, mobile testing units, surgeries, and screening centers. It ensures fast turnaround for patient results, reducing waiting times and improving patient management.
Q: Where is the Abbott ID NOW intended to be operated?
A: It is suitable for diverse healthcare settings including clinics, hospital departments, urgent care centers, and mobile or temporary testing sites, courtesy of its compact size, light weight, and ease of transport.
Q: What is the process for conducting a test on the Abbott ID NOW?
A: A trained healthcare professional loads a collected swab sample manually into the device, selects the appropriate test on the LCD touch screen, and the instrument automates the testing and result output. Results are displayed on-screen within minutes, and can be exported via USB or an optional network connection.
Q: How easy is it to maintain and clean the Abbott ID NOW device?
A: The instrument requires minimal maintenance. It is designed with smooth surfaces for easy wipe-down cleaning, helping maintain hygiene between uses. The proprietary software is pre-installed, and routine maintenance checks are user-friendly.